Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Research

| More

HSBC maintains Overweight rating on Maruti Suzuki India

Posted On: 2013-01-29 21:13:08

HSBC has maintained its Overweight rating on Maruti Suzuki India Limited (MSIL IN) in its recent flashnote on the company dated January 25, 2013.

HSBC maintains its OW rating after Maruti Suzuki India reported in-line 3Q13 financial results. The Strong EPS upgrades on favourable currency is also a key to its rating.

The report said concerns on the pace of demand revival remain, but in the near term the stock should be driven by a favourable currency movement (+20% FY14 EPS accretion from JPY).

HSBC remains Overweight and raises its FY14e EPS by 17% and DCF-based target price to INR1,820 from INR1,600.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Bandhan: How difficult it is to operate as a bank? - Religare Capital Market
Views on Impact of Rupee Depreciation on IT & Pharmaceuticals - Angel Broking
Views on Aurobindo Pharma receive USFDA Approval for Omeprazole & Ibandraonate Sodium - Angel Broking
Views on Lupin gets USFDA nod for Fenofibrate Tablets - Angel Broking
Views on Sun Pharma announce US FDA approval for Ximino™ - Angel Broking
Oil India - Q1: Subsidy burden impacts PAT - AXIS Capital
Tube Investments: Muted Q1; gradual recovery ahead - AXIS Capital
Astral Polytechnik: Q1 muted; gradual recovery ahead - AXIS Capital
Views on BEML Limited 1QFY2016 Results - Angel Broking
Views on Indag Rubber 1QFY2016 Results - Angel Broking
Views on KNR Constructions Limited 1QFY2016 Results - Angel Broking
Views on Amara Raja Batteries Ltd (ARBL) 1QFY2016 Results - Angel Broking
Views on MBL Infrastructure Ltd 1QFY2016 Results - Angel Broking
Views on on Coal India 1QFY2016 Results: Angel Broking
July CPI inflation eases, production up: DBS Group Research
Views on Cadila Healthcare 1QFY2016 Results - Angel Broking
Views on India Cement 1QFY2016 Results - Angel Broking
Views on IDBI Bank 1QFY2016 Results - Angel Broking
Views on Ashok Leyland Ltd 1QFY2016 Results - Angel Broking
Views on JK Lakshmi Cements 1QFY16 Results - Angel Broking
Views on Sun Pharmaceuticals 1QFY2016 Results - Angel Broking
Views on Tata steel 1QFY2016 Results - Angel Broking
Views on Apollo Tyres Ltd 1QFY2016 Results - Angel Broking
Views on State Bank of India 1QFY2016 Results - Angel Broking
Views on Minda Industries Ltd 1QFY2016 Results - Angel Broking
Views on Power Grid Corp 1QFY2016 Results - Angel Broking
Views on Garware Wall Ropes 1QFY2016 Results - Angel Broking
Views on Radico Khaitan 1QFY2016 Results - Angel Broking
Views on IL&FS Transportation Network 1QFY2016 Results - Angel Broking
Views on Mangalam Cement 1QFY2016 Results: Angel Broking
Views on PNC Infratech 1QFY2016 Results: Angel Broking
Views on Tata Motors 1QFY2016 Results: Angel Broking
Views on Mahindra & Mahindra 1QFY2016 Results: Angel Broking
MT Educare 1QFY2016 Results: Angel Broking
Views on Canara Bank 1QFY2016 Results: Angel Broking
Views on Shree Cement 4QFY2015 Results: Angel Broking
Views on Orient Cement 1QFY2016 Results: Angel Broking
Views on Hero Motocorp 1QFY2016 Results: Angel Broking
Views on HCL Technologies 4QFY2015 Results: Angel Broking
Views on Glaxo Pharmaceuticals 1QFY2016 Results: Angel Broking
Views on Alembic 1QFY2016 Results: Angel Broking
Views on ICICI Bank 1QFY2016 Results: Angel Broking
Views on Exide Industries Ltd 1QFY2016 Results: Angel Broking
BUY NRB Bearings: Anand Rathi Research
Views on Dr Reddys Lab 1QFY2016 Results: Angel Broking
Views on LG Balakrishnan & Bros 1QFY2016 Results: Angel Broking
Views on Dena Bank 1QFY2016 Results: Angel Broking
Views on Cipla - Launches the Pulmicort Respules 1mg /ml generic version: Angel Broking
Views on IPCA Labs 1QFY2016 Results: Angel Broking
Views on Indoco Remedies 1QFY2016 Results: Angel Broking


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2014